Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double Blind,Placebo-Controlled, Multicenter Study Evaluating the Safety and Pharmacokinetics of Different Dosing Regimens of Favipiravir in Healthy Adult Subjects and Adult Subjects With Uncomplicated Influenza

NCT01728753 is registered in ClinicalTrials.gov with MDVI, LLC as lead sponsor.

NCT NCT01728753
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01728753 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double Blind,Placebo-Controlled, Multicenter Study Evaluating the Safety and Pharmacokinetics of Different Dosing Regimens of Favipiravir in Healthy Adult Subjects and Adult Subjects With Uncomplicated Influenza
Lead sponsor
MDVI, LLC
Phase
Phase 1/2
Overall status
Completed
Start date
November 30, 2012
Completion date
February 28, 2013
Enrollment
550 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

influenza